Article
Glycemic and bodyweight effects of GIPR coding variation reflect differences in surface expression and intrinsic functional impairment.
Science advances - 4 Sept 2026
Manchanda Yusman, Desoki Rofaida, Gardner Eugene J, Perry John R B, Wainscott David B, Stutsman Cynthia, Langenberg Claudia, Coghlan Matthew, Bhatnagar Pallav, Ho Joseph D, Yonkunas Michael, Sloop Kyle W, Ong Ken K, Wareham Nicholas J, Tomas Alejandra, Jones Ben
Abstract excerpt
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is a major therapeutic target in type 2 diabetes and obesity. Missense variation in GIPR could confer phenotypic effects through alterations to constitutive activity or functional responses to GIP or pharmacological agonists. In this study, we aimed to provide a deep understanding of the molecular mechanisms that underpin the cellular and...
Read the complete abstract on PubMedTopics
- Humans
- Receptors, Gastrointestinal Hormone
- Molecular Dynamics Simulation
- Animals
- Blood Glucose
